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introduction: Newborn atrial flutter (AFL) can be treated by direct current cardioversion (DCC), transesophageal pacing (TEP) or medications. To 
date, no study has evaluated the cost effectiveness of cardioverting AFL in a newborn. The purpose is to compare the cost effectiveness of DCC, TEP 
and digoxin as treatment method for cardioverting newborn AFL.
materials and methods: A meta-analysis of success rates of cardioversion of AFL (age < 2 months) was imputed into a decision tree model, 
comparing the efficacy and cost of DCC, TEP, and digoxin. Assumed conversion rates were: DCC 82.5%, TEP 60% and digoxin 50%. Failed initial 
attempt at cardioversion resulted in progression to the next methodology until successful. Data was analyzed for cost effectiveness based upon 
2013 medicaid rates. Assumptions: IV access, all that had either DCC or TEP were sedated and intubated, NICU stay of 3 days for DCC/TEP and 4 
days for digoxin, failed conversion added additional day.
results: The cost analysis for cardioversion of AFL identified DCC as the most efficient method ($9,918), TEP next ($10,304) and digoxin as the 
least cost effective ($14,016.) The majority of the additional cost stems from prolonged stay and elevated failure rates.
conclusion: The most cost efficient method of cardioverting a neonate with AFL is DCC. It has the highest success rates, shorter length of stay and 
results in a cost saving of greater than $4,000.
 
